Abstract is: Julian Peto FRS is an English statistician and cancer epidemiologist at the London School of Hygiene and Tropical Medicine. He was Cancer Research UK Chair of Epidemiology at the Institute of Cancer Research from 1983 until 2010. From 1974 to 1983 he worked as a research scientist under Sir Richard Doll at the University of Oxford. He was educated at Taunton's School in Southampton, Balliol College, Oxford and Imperial College, London.His brother Richard Peto, with whom he has published work in mathematical statistics (see the logrank test), is also a distinguished epidemiologist. His research interests include the epidemiology of asbestos induced cancers, the epidemiology and genetics of breast cancer, and HPV screening to prevent cervical cancer.
| human | Q5 |
| P646 | Freebase ID | /m/03qj4yg |
| P8446 | Gateway to Research person ID | B585F8B1-1C47-42A5-9CE6-880A820CED32 |
| P3885 | History of Modern Biomedicine ID | julian-peto |
| P244 | Library of Congress authority ID | n85125424 |
| P1816 | National Portrait Gallery (London) person ID | mp140332 |
| P496 | ORCID iD | 0000-0002-1685-8912 |
| P214 | VIAF ID | 306073134 |
| P10832 | WorldCat Entities ID | E39PBJfMgmDW7kqrxfbpy6FdwC |
| P166 | award received | Fellow of the Royal Society | Q15631401 |
| P69 | educated at | Imperial College London | Q189022 |
| Balliol College | Q805285 | ||
| P108 | employer | London School of Hygiene & Tropical Medicine | Q1126189 |
| P734 | family name | Peto | Q21501421 |
| Peto | Q21501421 | ||
| Peto | Q21501421 | ||
| P735 | given name | Julian | Q17856012 |
| Julian | Q17856012 | ||
| P737 | influenced by | Richard Doll | Q740803 |
| P463 | member of | Royal Society | Q123885 |
| P106 | occupation | statistician | Q2732142 |
| epidemiologist | Q13416803 | ||
| P21 | sex or gender | male | Q6581097 |
| Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
| Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
| Q36021406 | 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium |
| Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
| Q35755874 | A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer |
| Q34115258 | A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes |
| Q57078703 | A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21 |
| Q56436562 | A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3 |
| Q29417036 | A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. |
| Q57092250 | A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk |
| Q37192589 | A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication |
| Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
| Q35089479 | A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population |
| Q36435849 | A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. |
| Q33573839 | A mortality study among workers in an English asbestos factory |
| Q36616549 | A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk |
| Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
| Q53478895 | Absence of linkage to the ataxia telangiectasia locus in familial breast cancer. |
| Q57319547 | Abstract P3-08-04: Impact of CYP3A variation on estrone levels and breast cancer risk |
| Q36610957 | Active and passive smoking and the risk of breast cancer in women aged 36-45 years: a population based case-control study in the UK. |
| Q39437211 | Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers |
| Q30747351 | Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease |
| Q36073563 | An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression |
| Q33634113 | An update of cancer mortality among chrysotile asbestos miners in Balangero, northern Italy |
| Q37891174 | Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q37292963 | Association of ESR1 gene tagging SNPs with breast cancer risk |
| Q46707380 | Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis |
| Q37684672 | Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. |
| Q43608304 | Association of genetic variants at 8q24 with breast cancer risk |
| Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
| Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
| Q60895214 | Asymptotically Efficient Rank Invariant Test Procedures |
| Q61124964 | Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia |
| Q60917552 | Author Correction: Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility |
| Q60912720 | Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma |
| Q42391232 | Authors' reply to letters from Egilman et al and Oliver et al. |
| Q24531993 | Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies |
| Q38914005 | BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer |
| Q35983298 | Bladder cancer mortality of workers exposed to aromatic amines: an updated analysis |
| Q35992188 | Bladder cancer mortality of workers exposed to aromatic amines: analysis of models of carcinogenesis. |
| Q36615404 | Body fatness and physical activity at young ages and the risk of breast cancer in premenopausal women |
| Q100457582 | Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk |
| Q43073201 | Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies |
| Q51696098 | Breast cancer onset in twins and women with bilateral disease. |
| Q34327945 | Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 |
| Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
| Q28215038 | Breast cancer susceptibility-A new look at an old model |
| Q44288178 | CYP3A variation, premenopausal estrone levels, and breast cancer risk |
| Q37627774 | CYP3A7*1C allele is associated with reduced levels of 2-hydroxylation pathway oestrogen metabolites |
| Q42345409 | Cancer in patients treated with immunosuppressive drugs |
| Q47648609 | Cancer mortality in relatives of women with breast cancer: the OPCS Study. Office of Population Censuses and Surveys |
| Q47648595 | Cancer mortality in relatives of women with ovarian cancer: the OPCS Study. Office of Population Censuses and Surveys |
| Q35994447 | Cancer mortality in the first degree relatives of young breast cancer patients |
| Q51807296 | Cancer survival is dependent on season of diagnosis and sunlight exposure. |
| Q38787237 | Cancer treatment trials--past failures, current progress and future prospects. |
| Q33577275 | Cancers of the respiratory tract in mustard gas workers |
| Q28385765 | Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk |
| Q31009526 | Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies |
| Q33402650 | Certified causes of death in patients with mesothelioma in South East England |
| Q36695625 | Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort |
| Q31135861 | Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies |
| Q35103477 | Cervical cancer and use of hormonal contraceptives: a systematic review |
| Q38520032 | Cohort study analysis with a FORTRAN computer program. |
| Q55652491 | Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs |
| Q37368000 | Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms |
| Q39352208 | Commentary: Frailty and cancer |
| Q73139263 | Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population |
| Q35891162 | Common breast cancer susceptibility loci are associated with triple-negative breast cancer |
| Q40034823 | Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk |
| Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
| Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q28247491 | Comprehensive analysis of the contribution of germline MYH variation to early-onset colorectal cancer |
| Q36026731 | Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer |
| Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
| Q27908468 | Consensus report of the 2015 Weinman International Conference on Mesothelioma |
| Q40991450 | Continuing increase in mesothelioma mortality in Britain. |
| Q57268128 | Contribution of Environmental Fibers to Respiratory Cancer |
| Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q57319824 | Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility |
| Q28388475 | Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations |
| Q36696957 | Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer |
| Q43231981 | Data protection, informed consent, and research |
| Q42624712 | Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study |
| Q24569560 | Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design |
| Q24569561 | Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples |
| Q27851413 | Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium |
| Q38160099 | Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials |
| Q59041387 | Erratum: Identification of the breast cancer susceptibility gene BRCA2 |
| Q35644167 | Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence |
| Q34057960 | Estimating causal effects of genetic risk variants for breast cancer using marker data from bilateral and familial cases |
| Q28396373 | Estimating the asbestos-related lung cancer burden from mesothelioma mortality |
| Q55715259 | Estimating the asbestos-related lung cancer burden from mesothelioma mortality. |
| Q37826158 | Eurogin 2010 roadmap on cervical cancer prevention |
| Q35653910 | Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk |
| Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
| Q38064070 | Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer |
| Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
| Q36692385 | Exposure to power frequency electric fields and the risk of childhood cancer in the UK |
| Q35141809 | Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study |
| Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
| Q37307305 | Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls |
| Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
| Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
| Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
| Q35063160 | Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk |
| Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
| Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
| Q37002930 | Five endometrial cancer risk loci identified through genome-wide association analysis |
| Q34979715 | Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium |
| Q114182808 | Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element |
| Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
| Q37128343 | Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients |
| Q37389405 | Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer |
| Q35194190 | Genetic heterogeneity and localization of a familial breast-ovarian cancer gene on chromosome 17q12-q21 |
| Q29619206 | Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium |
| Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
| Q54940815 | Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. |
| Q35925620 | Genetic predisposition to ductal carcinoma in situ of the breast |
| Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
| Q62583135 | Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma |
| Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
| Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
| Q36422109 | Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium |
| Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
| Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
| Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
| Q24645441 | Genome-wide association study identifies novel breast cancer susceptibility loci |
| Q52720511 | Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia. |
| Q47125417 | Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility |
| Q59566871 | Genomic analyses for age at menarche identify 389 independent signals and indicate BMI-independent effects of puberty timing on cancer susceptibility |
| Q38823212 | Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk |
| Q96432094 | Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk |
| Q57560745 | H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma |
| Q57337258 | HIV TESTING ON ALL PREGNANT WOMEN |
| Q92894714 | HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT |
| Q51824401 | HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. |
| Q31044179 | HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
| Q39182862 | Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor |
| Q36720814 | Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q58290724 | Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy |
| Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
| Q58743933 | Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma |
| Q34038964 | Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions |
| Q57170142 | Identification of nine new susceptibility loci for endometrial cancer |
| Q36922317 | Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14 |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q53007192 | Inconsistent association between the STK15 F31I genetic polymorphism and breast cancer risk. |
| Q40662115 | Inherited susceptibility to breast cancer |
| Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
| Q36300580 | Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study |
| Q34567194 | Lack of evidence on diets for obesity for children: a systematic review |
| Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
| Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
| Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
| Q34546040 | Lifetime risks of common cancers among retinoblastoma survivors |
| Q39352200 | Longer screening intervals are recommended following a negative HPV test in primary cervical screening |
| Q36619290 | Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer |
| Q28215462 | Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations |
| Q41340276 | Medical Research Council Childhood Leukaemia Trial VIII compared with trials II-VII: lessons for future management |
| Q114182490 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk |
| Q36333368 | Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. |
| Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
| Q34123806 | Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
| Q38519765 | Models for respiratory cancer in nickel refinery workers |
| Q35221378 | Multi-stage genome-wide association study identifies new susceptibility locus for testicular germ cell tumour on chromosome 3q25 |
| Q47696751 | Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations |
| Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
| Q36611488 | National study of colorectal cancer genetics |
| Q37356243 | Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. |
| Q39023154 | No breast cancer association for transforming growth factor-beta pathway colorectal cancer single nucleotide polymorphisms |
| Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
| Q39006292 | Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study |
| Q28388292 | Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study |
| Q33518244 | Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial |
| Q58290337 | P2-241 Evaluation of the national cervical screening programme in Chile |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q47143943 | PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
| Q34289136 | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche |
| Q36027791 | Passive smoking |
| Q52802875 | Past and current asbestos exposure and future mesothelioma risks in Britain: The Inhaled Particles Study (TIPS). |
| Q36859656 | Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
| Q55561867 | Polymorphisms, endogenous hormone levels and familial breast cancer risk in premenopausal women. |
| Q42481495 | Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q39569638 | Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors |
| Q31151637 | Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial |
| Q55443846 | Prof. Peto and Sir Richard Doll reply. |
| Q43807508 | Prospective study of cancer in patients with hypogammaglobulinaemia |
| Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
| Q36009422 | RAD51B in Familial Breast Cancer |
| Q42745414 | Radical surgery for mesothelioma |
| Q59006695 | Radon and the risks of cancer |
| Q59094168 | Radon risk reassessed |
| Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
| Q38590188 | Relationship of mortality to measures of environmental asbestos pollution in an asbestos textile factory |
| Q42546210 | Reply: comment on 'estimating the asbestos-related lung cancer burden from mesothelioma mortality'. |
| Q70774489 | Respiratory cancer mortality of Welsh nickel refinery workers |
| Q70219983 | Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood) |
| Q36648058 | Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-Control Study of Cervical Cancer |
| Q37300024 | Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. |
| Q53010655 | Search for low penetrance alleles for colorectal cancer through a scan of 1467 non-synonymous SNPs in 2575 cases and 2707 controls with validation by kin-cohort analysis of 14 704 first-degree relatives. |
| Q45984758 | Sexual behavior and HPV infection in British women, by postal questionnaires and telephone interviews. |
| Q36621538 | Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort |
| Q69882451 | Stress and cancer surveys |
| Q36615665 | The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions |
| Q49817640 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. |
| Q24650064 | The European mesothelioma epidemic |
| Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
| Q59587479 | The MARS feasibility trial: conclusions not supported by data – Authors' reply |
| Q37574893 | The Mesothelioma and Radical surgery randomized controlled trial: the Mars feasibility study |
| Q36173887 | The PapilloCheck Assay for Detection of High-Grade Cervical Intraepithelial Neoplasia |
| Q34334371 | The cervical cancer epidemic that screening has prevented in the UK. |
| Q38928159 | The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds |
| Q37804082 | The contribution of inherited predisposition to cancer incidence |
| Q36617025 | The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. |
| Q38976794 | The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women |
| Q35864053 | The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis |
| Q73604908 | The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2 |
| Q35868043 | The search for low-penetrance cancer susceptibility alleles |
| Q37695585 | Time since first sexual intercourse and the risk of cervical cancer |
| Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
| Q92994868 | Two truncating variants in FANCC and breast cancer risk |
| Q53551413 | Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study. |
| Q52725335 | Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer. |
| Q98190418 | Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic |
| Q120170805 | Weekly population testing could stop this pandemic and prevent the next |
| Q37414133 | rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk |
| Julian Peto | wikipedia |
Search more.